Episode 160: NASDAQ $GNPX is Advancing Cancer and Diabetes Treatments
In this exclusive Global One Media interview, Genprex, Inc. (NASDAQ: GNPX) Chief Financial Office...
Stocks To Watch · Global One Media Pte. Ltd.
Audio is streamed directly from the publisher (pdcn.co) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this exclusive Global One Media interview, Genprex, Inc. (NASDAQ: GNPX) Chief Financial Officer Ryan M. Confer delves into his company's groundbreaking work so far in clinical-stage gene therapy.
Mr. Confer explains how Genprex's technologies have been designed to address the needs of large patient populations with cancer and diabetes who currently have limited treatment options and talks about the firm’s upcoming milestones.
Learn more about Genprex by visiting their website: https://www.genprex.com/
Watch the full YouTube interview here: https://www.youtube.com/watch?v=PQT-M_khrXw
And follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1